Medtronic taps Asia markets for growth

MedTech |  Analysis | By Piyusha Chatterjee | 0 Comment | 26 Nov, 2012

Medtronic is putting in place plans to grow its emerging markets' revenue to 20 percent of the overall revenue in the next few years. In FY'12, the US-headquartered medical devices company ...Read more

Jon Samsel is new CMO of DocDoc

MedTech |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jan, 2013

Singapore: DocDoc, Singapore's healthcare service company, has appointed Mr Jon Samsel as its chief marketing officer (CMO) with global responsibility. The appointment is effective immediat...Read more

Malaysian, Chinese medtech firms form JV

MedTech |  News | By BioSpectrum Bureau  | 0 Comment | 28 Dec, 2012

Singapore: Malaysia-based medical device producers, OSA Niaga and Straits Orthopedics entered into a joint venture (JV) with Beijing-based multinational medical supplier Naton Medical to pr...Read more

Health tech to help chronic and aging patients

MedTech |  Opinion | By BioSpectrum Bureau  | 0 Comment | 27 Nov, 2012

The challenges of 21st century healthcare will soon exacerbate if two colliding forces are not addressed – rising chronic disease and aging populations. The World Health Organization...Read more

St Jude launches 3-D heart vessel imager

MedTech |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2013

Singapore: St Jude Medical, a global medical device company, launched Ilumien Optis System, a next-generation technology designed to help physicians make personalized stenting decisions bas...Read more

UBI doubled its revenue to $29.6 mn in FY 2012

MedTech |  News | By BioSpectrum Bureau  | 0 Comment | 14 Feb, 2013

Singapore: Universal Biosensors reported its unaudited financial result for FY 2012 including a doubling of total revenues to $29.6 million for the year. The strong growth in revenue was la...Read more

Geneva scientist builds low-cost fake drug detector

MedTech |  News | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2013

Singapore: Associate professor Serge Rudaz of Geneva University's School of Pharmaceutical Sciences has invented a low cost machine that can detect weakened or counterfeit drugs. Prof Ruda...Read more

Agilent LC/MS for 'dried blood-spot analysis'

MedTech |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

Singapore: Agilent Technologies has introduced the Agilent Automated Card Extraction LC/MS system, a fully integrated instrument for the analysis of dried blood spots and other dried media....Read more

ResMed builds on partnerships for growth

MedTech |  Analysis | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2012

Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisitions and product expansion in the European region in 2011. ResMed took...Read more

What are angel investors looking for?

MedTech |  Influencers | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2012

Healthcare, biotech, pharma and life sciences are sectors that involve patient bunch of people who are willing to wait for a good number of years before their products or research commercia...Read more

Nanoparticles: A unique approach to cancer treatment

MedTech |  News | By Nandita Singh | 0 Comment | 14 Mar, 2012

Nanoparticles as a drug delivery system enables unique approaches for cancer treatment. Over the last two decades, a large number of nanoparticle delivery systems have been developed for ca...Read more

Abbott recalls FreeStyle Blood Glucose Meter

MedTech |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2014

Singapore: Abbott is voluntarily conducting a recall for the FreeStyle Blood Glucose Meter and the FreeStyle Flash Blood Glucose Meter. These two meters have not been in production since 20...Read more

Lab-on-chips usher in an era of shrinking labs

MedTech |  Analysis | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

Gone would be the days when patients will have to walk-in to their pathologists for diagnosis of a disease and wait for several weeks to get the result for tests conducted by conventional m...Read more

Mr Harish Nuggehalli & Mr Ashwin Sreenivasan: Focus on quality, cost will intensify in 2013

MedTech |  Opinion | By BioSpectrum Bureau  | 0 Comment | 26 Dec, 2012

We are looking to take several initiatives in 2013, including the development of a local eco-system of vendors by connecting dots and generate business for them even if Yethimed is not part...Read more

China to buy Gamma Knife surgery worth $25 mn

MedTech |  News | By BioSpectrum Bureau  | 0 Comment | 12 Sep, 2013

Singapore: National Health and Family Planning Commission (NHFPC) of China is to purchase seven Leksell Gamma Knife Perfexion units at $25 million. These units have been developed by Stockh...Read more

Irish medtech firm Mainstay starts clinical trials

MedTech |  News | By BioSpectrum Bureau  | 0 Comment | 10 Mar, 2014

Singapore: Irish medtech firm Mainstay Medical has started its clinical trials on Implanted Reactiv8 unit that is being designed to stabilize spinal muscles with electrical impulses. Targe...Read more

Co-Diagnostics, DNA Logix JV to target poor nations

MedTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2013

Singapore: US-based Co-Diagnostics and DNA Logix have formed a joint venture, Co-Diagnostics HBDC to address diagnostic problems for infectious diseases unique to high burden developing cou...Read more

Amaranth gets $20 mn from DCP Management

MedTech |  News | By BioSpectrum Bureau  | 0 Comment | 08 Oct, 2013

Singapore: Singapore-based Amaranth Medical, a privately-held medical device company, has closed $20 million series B financing led by new investor DCP Management, Singapore. Existing inve...Read more